Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain-Reference-Cited by-同舟云学术

Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain

Published:2015-04 Issue:17 Volume:290 Page:11061-11074
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Tokarski John S.,Zupa-Fernandez Adriana,Tredup Jeffrey A.,Pike Kristen,Chang ChiehYing,Xie Dianlin,Cheng Lihong,Pedicord Donna,Muckelbauer Jodi,Johnson Stephen R.,Wu Sophie,Edavettal Suzanne C.,Hong Yang,Witmer Mark R.,Elkin Lisa L.,Blat Yuval,Pitts William J.,Weinstein David S.,Burke James R.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference44 articles.

1. Targeting IL-17 and TH17 cells in chronic inflammation;Miossec;Nat. Rev. Drug Discov,2012

2. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses;Volpe;Nat. Immunol,2008

3. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease;Geremia;J. Exp. Med,2011

4. Ustekinumab induction and maintenance therapy in refractory Crohn's disease;Sandborn;N. Engl. J. Med,2012

5. Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis;Strober;Br. J. Dermatol,2011

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses;Arthritis & Rheumatology;2024-07

2. Small molecule drug discovery targeting the JAK-STAT pathway;Pharmacological Research;2024-06

3. Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition;Journal of Clinical Medicine;2024-05-24

4. Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients;Expert Opinion on Drug Metabolism & Toxicology;2024-03-28

5. Treatment of chronic plaque psoriasis: An overview on current update;Pharmacological Research - Reports;2024-03